中文 | English
Return
Total: 79 , 1/8
Show Home Prev Next End page: GO
Author:( Xiuying XU)

1.A STUDY OF PSS THERAPY ON REFRACTORY NEPHROSIS IN CHILDREN

Wenli ZHOU ; Liyuan XU ; Xiuying WANG

Chinese Journal of Marine Drugs 1994;0(02):-

2.Correlation between ischemic preconditioning and left ventricular diastolic function in diabetic patients with acute myocardial infarction

Yanting SHENG ; Qiuyun YU ; Xiuying XU

Academic Journal of Second Military Medical University 2000;0(07):-

3.Serum soluble interleukin-2 receptor levels in patients with posthepatitis-B cirrhosis.

Xiuying XU ; Jing CHI ; Tian SHI

Chinese Journal of Practical Internal Medicine 2000;0(11):-

4.Action of corn filament beverage on falling blood fat in hyperlipemia rats and mice

Dawei WANG ; Xiuying XU ; Tingting LIU

Journal of Jilin University(Medicine Edition) 2006;0(06):-

5.Changes of Markers of Prethrombotic State and Their Clinical Significance with Heart Failure

Liying MU ; Fenghe DU ; Xiuying XU

Journal of Medical Research 2006;0(08):-

6.Treatment of syphilis in pregnancy and its perinatal prognosis

Yan XU ; Xiuying LU ; Yi LING

Chinese Journal of Obstetrics and Gynecology 2001;0(08):-

7.Determination of Demethylbellidifolin in Different Parts of Swertia Davidi Franch. by HPLC

Youli ZHANG ; Yimin ZHENG ; Xiuying XU ; Shanquan FU

China Pharmacy 2005;0(15):-

8.RP-HPLC Analysis and Pharmacokinetics Study of Serum Carthamin in Mice

Xiuying XU ; Yimin ZHENG ; Shanquan FU ; Yumei HAN ; Ali WANG

China Pharmacy 2007;0(33):-

9.Efficacy of fexofenadine hydrochloride tablets at tapering doses for the treatment of chronic spontaneous ;urticaria:a clinical observation

Zhiqiang SONG ; Na LUO ; Shuguang CHEN ; Jing XU ; Xiuying HUANG

Chinese Journal of Dermatology 2016;49(8):547-550

10.Determination of Quercitrin in Saxifrage by HPLC

Yimin ZHENG ; Yanhong YANG ; Xiuying XU ; Shanquan FU

China Pharmacy 2005;0(18):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 79 , 1/8 Show Home Prev Next End page: GO